Compare · BIOS vs CPUH
BIOS vs CPUH
Side-by-side comparison of BioPlus Acquisition Corp. (BIOS) and Compute Health Acquisition Corp. (CPUH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOS and CPUH operate in Blank Checks (Finance), so they compete in similar markets.
- CPUH carries a market cap of $1.05B.
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Compute Health Acquisition Corp.
Compute Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilmington, Delaware.
Latest BIOS
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by BioPlus Acquisition Corp.
- SEC Form 25-NSE filed by BioPlus Acquisition Corp.
- SEC Form RW filed by BioPlus Acquisition Corp.
- Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
- BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Latest CPUH
- SEC Form 15-12G filed by Compute Health Acquisition Corp.
- SEC Form 4: Compute Health Sponsor Llc was granted 2,088,327 shares and returned 2,088,327 shares to the company (Amendment)
- SEC Form 4: Harsh Michael was granted 21,120 shares and returned 31,120 shares to the company, closing all direct ownership in the company
- SEC Form 4: Watanabe Gwendolyn A was granted 21,120 shares and returned 21,120 shares to the company
- SEC Form 25-NSE filed by Compute Health Acquisition Corp.
- Allurion Debuts as a Publicly Traded Company on the NYSE
- SEC Form DEFA14A filed by Compute Health Acquisition Corp.
- Compute Health Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion
- SEC Form 425 filed by Compute Health Acquisition Corp.